A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy

Alzheimer's and Dementia: Translational Research and Clinical Interventions - Tập 5 - Trang 579-591 - 2019
Megan Torvell1,2,3,4, David W. Hampton1,2, Peter Connick5, Alasdair M.J. MacLullich6, Colm Cunningham7, Siddharthan Chandran1,2,3,5
1Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK
2Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, UK
3UK Dementia Research Institute at University of Edinburgh, Edinburgh, UK
4UK Dementia Research Institute at University of Cardiff, Cardiff, UK
5The Anne Rowling Regenerative Neurology Clinic, University of Edinburgh, Edinburgh, Midlothian, UK
6Edinburgh Delirium Research Group, Geriatric Medicine, University of Edinburgh, Edinburgh, UK
7Trinity Biomedical Sciences Institute and Trinity College Institute of Neuroscience, School of Biochemistry and Immunology, Trinity College Dublin, Dublin, Ireland

Tóm tắt

AbstractIntroductionNeuroinflammation, which contributes to neurodegeneration, is a consistent hallmark of dementia. Emerging evidence suggests that systemic inflammation also contributes to disease progression.MethodsThe ability of systemically administered lipopolysaccharide (LPS ‐ 500 μg/kg) to effect acute and chronic behavioural changes in C57BL/6 and P301S tauopathy mice was assessed. Markers of pathology were assessed in the brain and spinal cord.ResultsP301S mice display regional microgliosis. Systemic LPS treatment induced exaggerated acute sickness behaviour and motor dysfunction in P301S mice compared with wild‐type controls and advanced the onset and accelerated chronic decline. LPS treatment was associated with increased tau pathology 24 hours after LPS injection and spinal cord microgliosis at the end stage.DiscussionThis is the first demonstration that a single systemic inflammatory episode causes exaggerated acute functional impairments and accelerates the long‐term trajectory of functional decline associated with neurodegeneration in a mouse model of human tauopathy. The findings have relevance to management of human dementias.

Tài liệu tham khảo

10.1038/ng.2802 10.1038/ng.439 10.1016/j.biopsych.2014.05.006 10.1001/archneurol.2010.201 10.1056/NEJMoa1211851 10.1056/NEJMoa1211103 10.1111/cge.12108 10.1097/01.wad.0000165511.52746.1f 10.1001/archneur.61.5.668 Walker K.A., 2019, Systemic inflammation during midlife and cognitive change over 20 years. The ARIC Study, Neurology, 92, e1256 10.1212/WNL.0b013e3181b6bb95 10.1016/j.biopsych.2008.07.024 10.1038/nri2015 10.1523/JNEUROSCI.2868-05.2005 10.1016/j.neuron.2010.08.023 10.1186/1742-2094-7-56 Skelly D.T., 2018, Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL‐1‐dependent mechanisms, Mol Psychiatry, 24, 1533 10.1016/j.jagp.2014.08.005 10.1523/JNEUROSCI.0834-10.2010 10.1523/JNEUROSCI.22-21-09340.2002 10.1016/S0002-9440(10)63421-9 10.1186/1742-2094-8-50 Paxinos G., 2004, The Mouse Brain in Stereotaxic Coordinates 10.1038/nmeth.2019 Schneider CAR W.S., 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089 10.1038/nprot.2008.73 10.1001/jama.2010.1553 10.1016/S1474-4422(14)70017-1 10.1186/s12974-018-1059-y Polito A., 2010, Human and experimental septic shock are characterized by depletion of lipid droplets in the adrenals, Intensive Care Med, 36, 1852, 10.1007/s00134-010-1987-1 10.1016/j.expneurol.2007.01.003 10.1016/j.jchemneu.2005.07.003 10.1016/j.jamda.2010.04.010 10.1523/JNEUROSCI.2614-05.2005 10.1096/fj.05-3776fje 10.1093/brain/awn101 10.1016/j.nbd.2007.11.012 10.1016/j.neurobiolaging.2014.03.025 10.1016/j.bbi.2007.08.014 10.1016/j.bbi.2008.09.002 10.1016/j.ajpath.2011.02.012 10.1186/s40478-015-0203-5 10.1038/nn.4222 10.1523/JNEUROSCI.20-16-06309.2000 10.1016/j.brainres.2008.02.084 10.1016/0304-3940(93)90147-D 10.1093/jnen/60.6.647 10.1038/s41586-018-0023-4 Rakic S., 2018, Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease, Acta Neuropathol Commun, 6, 88, 10.1186/s40478-018-0592-3 10.1007/s00401-016-1630-5 10.3233/JAD-131843 10.1016/S0002-9440(10)62274-2 10.1007/BF00296797 10.1097/00005072-199703000-00007 10.1093/brain/awv081 10.1111/j.1460-9568.2011.07764.x 10.1016/S1474-4422(15)00092-7
Thông tin
Thông tin xuất bản

Alzheimer's and Dementia: Translational Research and Clinical Interventions

Tập 5

579-591

Thông tin tác giả